HI
JAZZ icon

Harbour Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Harbour Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Buy
1,384
+20
+1% +$3.5K ﹤0.01% 1383
2025
Q4 		$232K Buy
1,364
+8
+0.6% +$1.23K ﹤0.01% 1207
2025
Q3 		$179K Hold
1,356
– – ﹤0.01% 1285
2025
Q2 		$144K Hold
1,356
– – ﹤0.01% 1334
2025
Q1 		$168K Sell
1,356
-15
-1% -$1.96K ﹤0.01% 1177
2024
Q4 		$169K Hold
1,371
– – ﹤0.01% 1125
2024
Q3 		$153K Sell
1,371
-18
-1% -$1.97K ﹤0.01% 1130
2024
Q2 		$148K Buy
1,389
+1
+0.1% +$110 0.01% 1061
2024
Q1 		$167K Sell
1,388
-2
-0.1% -$245 0.01% 985
2023
Q4 		$171K Buy
1,390
+3
+0.2% +$374 0.01% 921
2023
Q3 		$180K Buy
1,387
+5
+0.4% +$666 0.01% 823
2023
Q2 		$171K Sell
1,382
-7
-0.5% -$942 0.01% 856
2023
Q1 		$203K Sell
1,389
-10
-0.7% -$1.48K 0.01% 762
2022
Q4 		$223K Sell
1,399
-14
-1% -$2.05K 0.01% 707
2022
Q3 		$220K Hold
1,413
– – 0.01% 650
2022
Q2 		$220K Buy
+1,413
New +$218K 0.01% 650
2021
Q4 		$182K Sell
1,430
-167
-10% -$21.9K 0.01% 752
2021
Q3 		$208K Sell
1,597
-23
-1% -$3.48K 0.01% 1002
2021
Q2 		$288K Buy
1,620
+1
+0.1% +$173 0.01% 885
2021
Q1 		$266K Buy
+1,619
New +$266K 0.01% 848

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Harbour Investments's JAZZ Position: Q1 2026 in Review

Harbour Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 1.5% in Q1 2026, buying an estimated $3.5K and bringing the position to 1,384 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Harbour Investments first reported a position in JAZZ in Q1 2021 and has held it in 20 quarters since. The position peaked at $288K in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Harbour Investments held 1,384 shares of Jazz Pharmaceuticals worth $262K as of Q1 2026.
  • Harbour Investments bought 20 Jazz Pharmaceuticals shares in Q1 2026, an estimated $3.5K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1383 holding.
  • Harbour Investments first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Jazz Pharmaceuticals position peaked at $288K in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.